SEATTLE -- U.S. researchers gave the first shot to the first person in a test of an experimental coronavirus vaccine Monday -- leading off a worldwide hunt for protection even as the pandemic surges.

The Food and Drug Administration has given approval to a second U.S. company to begin a small safety test of a vaccine against the new coronavirus. Inovio Pharmaceuticals says it has FDA permission ...

COVID-19 cases continue to climb week-over-week as summer draws to a close, according to U.S. health data. Some regions of the United States are experiencing higher rates of positive COVID-19 tests ...

As summer comes to an end, COVID-19 cases are on the rise again in California. While respiratory viruses usually peak in the winter, the novel coronavirus can also surge in the warmer months.

Moderna said it has administered its first dose in a Phase 3 trial of a combination COVID-19 and influenza shot, mRNA‐1083, which the company hopes can garner final regulatory approval by 2025.

The magnitude of loss from COVID-19 is now on par with suffering the 9/11 attacks every day. The US averaged more than 3,223 COVID-19 deaths a day over the past week, according to Johns Hopkins ...

Respiratory viruses are more active from October through March. Use over-the-counter COVID tests and clinical tests to distinguish respiratory viruses. Health officials advise vaccines, testing and ...